# Mesenchymal Stem Cells for Progressive Multiple Sclerosis_Sweden

> **NCT03778333** · PHASE1 · COMPLETED · sponsor: **Karolinska Institutet** · enrollment: 7 (actual)

## Conditions studied

- Autologous Mesenchymal Stem Cells
- Multiple Sclerosis

## Interventions

- **BIOLOGICAL:** Autologous mesenchymal stem cells

## Key facts

- **NCT ID:** NCT03778333
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12-01
- **Primary completion:** 2016-12
- **Final completion:** 2016-12-31
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2023-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03778333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03778333, "Mesenchymal Stem Cells for Progressive Multiple Sclerosis_Sweden". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03778333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*